271 related articles for article (PubMed ID: 33737307)
21. Intensive multimodality treatment for children with newly diagnosed CNS atypical teratoid rhabdoid tumor.
Chi SN; Zimmerman MA; Yao X; Cohen KJ; Burger P; Biegel JA; Rorke-Adams LB; Fisher MJ; Janss A; Mazewski C; Goldman S; Manley PE; Bowers DC; Bendel A; Rubin J; Turner CD; Marcus KJ; Goumnerova L; Ullrich NJ; Kieran MW
J Clin Oncol; 2009 Jan; 27(3):385-9. PubMed ID: 19064966
[TBL] [Abstract][Full Text] [Related]
22. Focal versus craniospinal radiation for disseminated atypical teratoid/rhabdoid tumor following favorable response to systemic therapy.
Aridgides PD; Mahajan A; Eaton B; Wang D; Timmerman B; Früwald MC; Nemes K; Deck J; Yamasaki K; Von Hoff K; Lafay-Cousin L; Reddy A; Lo AC
Pediatr Blood Cancer; 2023 Jul; 70(7):e30351. PubMed ID: 37073482
[TBL] [Abstract][Full Text] [Related]
23. Description of a new oncogenic mechanism for atypical teratoid rhabdoid tumors in patients with ring chromosome 22.
Byers HM; Adam MP; LaCroix A; Leary SE; Cole B; Dobyns WB; Mefford HC
Am J Med Genet A; 2017 Jan; 173(1):245-249. PubMed ID: 27734605
[TBL] [Abstract][Full Text] [Related]
24. Meta-Analysis of Treatment Modalities in Metastatic Atypical Teratoid/Rhabdoid Tumors in Children.
Underiner RM; Eltobgy M; Stanek JR; Finlay JL; AbdelBaki MS
Pediatr Neurol; 2020 Jul; 108():106-112. PubMed ID: 32402552
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of MYC attenuates tumor cell self-renewal and promotes senescence in SMARCB1-deficient Group 2 atypical teratoid rhabdoid tumors to suppress tumor growth in vivo.
Alimova I; Pierce A; Danis E; Donson A; Birks DK; Griesinger A; Foreman NK; Santi M; Soucek L; Venkataraman S; Vibhakar R
Int J Cancer; 2019 Apr; 144(8):1983-1995. PubMed ID: 30230537
[TBL] [Abstract][Full Text] [Related]
26. Age of diagnosis clinically differentiates atypical teratoid/rhabdoid tumors diagnosed below age of 3 years: a database study.
Lu VM; Di L; Eichberg DG; Luther EM; Shah AH; Daniels DJ; Maher OM; Niazi TN
Childs Nerv Syst; 2021 Apr; 37(4):1077-1085. PubMed ID: 33236183
[TBL] [Abstract][Full Text] [Related]
27. Molecular subgrouping of atypical teratoid/rhabdoid tumors-a reinvestigation and current consensus.
Ho B; Johann PD; Grabovska Y; De Dieu Andrianteranagna MJ; Yao F; Frühwald M; Hasselblatt M; Bourdeaut F; Williamson D; Huang A; Kool M
Neuro Oncol; 2020 May; 22(5):613-624. PubMed ID: 31889194
[TBL] [Abstract][Full Text] [Related]
28. Atypical teratoid/rhabdoid tumor (ATRT) arising from the 3rd cranial nerve in infants: a clinical-radiological entity?
Oh CC; Orr BA; Bernardi B; Garré ML; Rossi A; Figà-Talamanca L; Robinson GW; Patay Z
J Neurooncol; 2015 Sep; 124(2):175-83. PubMed ID: 26148473
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of nuclear export restores nuclear localization and residual tumor suppressor function of truncated SMARCB1/INI1 protein in a molecular subset of atypical teratoid/rhabdoid tumors.
Pathak R; Zin F; Thomas C; Bens S; Gayden T; Karamchandani J; Dudley RW; Nemes K; Johann PD; Oyen F; Kordes U; Jabado N; Siebert R; Paulus W; Kool M; Frühwald MC; Albrecht S; Kalpana GV; Hasselblatt M
Acta Neuropathol; 2021 Aug; 142(2):361-374. PubMed ID: 34003336
[TBL] [Abstract][Full Text] [Related]
30. Overall Survival of Primary Intracranial Atypical Teratoid Rhabdoid Tumor Following Multimodal Treatment: A Pooled Analysis of Individual Patient Data.
Ma XJ; Li D; Wang L; Hao SY; Zhang LW; Zhang JT; Wu Z
Neurosurg Rev; 2020 Feb; 43(1):281-292. PubMed ID: 30535934
[TBL] [Abstract][Full Text] [Related]
31. Imaging and multi-omics datasets converge to define different neural progenitor origins for ATRT-SHH subgroups.
Lobón-Iglesias MJ; Andrianteranagna M; Han ZY; Chauvin C; Masliah-Planchon J; Manriquez V; Tauziede-Espariat A; Turczynski S; Bouarich-Bourimi R; Frah M; Dufour C; Blauwblomme T; Cardoen L; Pierron G; Maillot L; Guillemot D; Reynaud S; Bourneix C; Pouponnot C; Surdez D; Bohec M; Baulande S; Delattre O; Piaggio E; Ayrault O; Waterfall JJ; Servant N; Beccaria K; Dangouloff-Ros V; Bourdeaut F
Nat Commun; 2023 Oct; 14(1):6669. PubMed ID: 37863903
[TBL] [Abstract][Full Text] [Related]
32. Intensive induction chemotherapy followed by high dose chemotherapy with autologous hematopoietic progenitor cell rescue in young children newly diagnosed with central nervous system atypical teratoid rhabdoid tumors.
Gardner SL; Asgharzadeh S; Green A; Horn B; McCowage G; Finlay J
Pediatr Blood Cancer; 2008 Aug; 51(2):235-40. PubMed ID: 18381756
[TBL] [Abstract][Full Text] [Related]
33. Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System in Children under the Age of 3 Years.
Park M; Han JW; Hahn SM; Lee JA; Kim JY; Shin SH; Kim DS; Yoon HI; Hong KT; Choi JY; Kang HJ; Shin HY; Phi JH; Kim SK; Lee JW; Yoo KH; Sung KW; Koo HH; Lim DH; Shin HJ; Kim H; Koh KN; Im HJ; Ahn SD; Ra YS; Baek HJ; Kook H; Jung TY; Choi HS; Kim CY; Park HJ; Lyu CJ
Cancer Res Treat; 2021 Apr; 53(2):378-388. PubMed ID: 33138347
[TBL] [Abstract][Full Text] [Related]
34. Survival outcomes in atypical teratoid rhabdoid tumor for patients undergoing radiotherapy in a Surveillance, Epidemiology, and End Results analysis.
Buscariollo DL; Park HS; Roberts KB; Yu JB
Cancer; 2012 Sep; 118(17):4212-9. PubMed ID: 22213196
[TBL] [Abstract][Full Text] [Related]
35. Continuous remission of newly diagnosed and relapsed central nervous system atypical teratoid/rhabdoid tumor.
Zimmerman MA; Goumnerova LC; Proctor M; Scott RM; Marcus K; Pomeroy SL; Turner CD; Chi SN; Chordas C; Kieran MW
J Neurooncol; 2005 Mar; 72(1):77-84. PubMed ID: 15803379
[TBL] [Abstract][Full Text] [Related]
36. Atypical teratoid/rhabdoid tumors of the central nervous system: management and outcomes.
Chen ML; McComb JG; Krieger MD
Neurosurg Focus; 2005 Jun; 18(6A):E8. PubMed ID: 16048294
[TBL] [Abstract][Full Text] [Related]
37. Does Stereotactic Radiosurgery Positively Impact the Local Control of Atypical Teratoid Rhabdoid Tumors?
Spina A; Gagliardi F; Boari N; Bailo M; Mortini P
World Neurosurg; 2017 Aug; 104():612-618. PubMed ID: 28461278
[TBL] [Abstract][Full Text] [Related]
38. Spontaneous Regression of Atypical Teratoid Rhabdoid Tumor Without Therapy in a Patient With Uncommon Regional Inactivation of SMARCB1 ( hSNF5/INI1).
Peterson JEG; Bavle A; Mehta VP; Rauch RA; Whitehead WE; Mohila CA; Su JM; Adesina AM
Pediatr Dev Pathol; 2019; 22(2):161-165. PubMed ID: 30470167
[TBL] [Abstract][Full Text] [Related]
39. Clinicopathologic prognostic factors in childhood atypical teratoid and rhabdoid tumor of the central nervous system: a multicenter study.
Dufour C; Beaugrand A; Le Deley MC; Bourdeaut F; André N; Leblond P; Bertozzi AI; Frappaz D; Rialland X; Fouyssac F; Edan C; Grill J; Quidot M; Varlet P
Cancer; 2012 Aug; 118(15):3812-21. PubMed ID: 22180295
[TBL] [Abstract][Full Text] [Related]
40. Current Molecular and Clinical Landscape of ATRT - The Link to Future Therapies.
Gastberger K; Fincke VE; Mucha M; Siebert R; Hasselblatt M; Frühwald MC
Cancer Manag Res; 2023; 15():1369-1393. PubMed ID: 38089834
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
